iconiifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Valiant Laboratories IPO to open on September 27; fixed price band at Rs 133-140 per share

23 Sept 2023 , 10:25 PM

Valiant Laboratories is set to launch its maiden public issue on September 27, with an IPO price band set at Rs 133-140 per share. Here are some key details about the IPO:

1. IPO Size: The initial public offering comprises only a fresh issue of 1.09 crore equity shares by the company, and there is no offer-for-sale portion in the issue.

2. Anchor Book: The anchor book of the offer, which is a part of the qualified institutional buyers' (QIB) portion, will be opened for a day on September 26, 2023.

3. Closing Date: The IPO will close on October 3, 2023.

4. Allotment Date: The basis of allotment of IPO shares will be finalized by the company in consultation with the NSE by October 5, 2023.

5. Listing Date: Valiant Laboratories is expected to make its debut on the BSE and NSE on October 9, 2023.

6. Fund Utilization: The company plans to raise Rs 152.46 crore via the IPO at the upper price band. The net fresh issue proceeds will be used for setting up a manufacturing facility for specialty chemicals (ketene and diketene derivatives products) in Bharuch, Gujarat, owned by its subsidiary, Valiant Advanced Sciences, and for working capital requirements of the said subsidiary. The remaining funds will be used for general corporate purposes.

7. Minimum and Maximum Investment: Retail investors can bid for a minimum of 105 equity shares, and in multiples of 105 shares thereafter. The minimum application size for retail investors would be Rs 14,700 (105 shares), and their maximum investment in the offer would be Rs 1,91,100 (for 1,365 shares), as they cannot exceed their investment limit beyond Rs 2 lakh in the IPO. High net worth individuals, with an investment limit of Rs 2 lakh to Rs 10 lakh, can invest a minimum of Rs 2,05,800 (for 1,470 shares) and a maximum of Rs 9,99,600 (for 7,140 shares) at the upper price band.

8. Merchant Banker and Registrar: Unistone Capital is the merchant banker to the issue, while Link Intime India is the registrar to the offer.

The pharmaceutical company specializing in the manufacturing of active pharmaceutical ingredients (API) and bulk drugs, primarily focusing on Paracetamol, is predominantly owned by its promoters. Dhanvallabh Ventures LLP, in particular, holds a significant 62.5 percent share in the company. Additionally, the promoters Shantilal Shivji Vora and Santosh Shantilal Vora each possess a 10.01 percent stake in the company.

Valiant Organics, which is a publicly listed entity on both the BSE and NSE, acts as the promoter of Dhanvallabh Ventures LLP, holding a substantial 73.15 percent stake in the LLP.

Paracetamol, a widely used analgesic worldwide, finds numerous applications in the treatment of various conditions, including headaches, muscle aches, arthritis, backaches, toothaches, as well as for alleviating cold and fever symptoms.

Valiant Laboratories IPO

Related Tags

  • Valiant Laboratories IPO
  • Valiant Laboratories IPO allotment date
  • Valiant Laboratories IPO closing date
  • Valiant Laboratories IPO GMP
  • Valiant Laboratories IPO listing date
  • Valiant Laboratories IPO opening date
  • Valiant Laboratories IPO price band
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

4 Mar 2024   |   09:10 AM
4 Mar 2024   |   06:22 PM
4 Mar 2024   |   08:40 AM
4 Mar 2024   |   06:37 PM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.